PRO1107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRO1107, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: PRO1107 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]